• Return to Headlines

Shares of Progenics Pharm Are Down on Strong Volume (PGNX)

By David Diaz

The price of Progenics Pharm shares has slipped to $6.17 (a 15.5% change) on heavy trading volume. About 2.3 million shares have been traded today, as compared to the 30-day average volume of 1.8 million shares. Spikes in volume can validate a breakout or signify a potential turning point.

SmarTrend is monitoring the recent change of momentum in Progenics Pharm. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Progenics Pharm in search of a potential trend change.

In the past 52 weeks, Progenics Pharm share prices have been bracketed by a low of $5.01 and a high of $9.42 and are now at $6.11, 22% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 0.5% while the 200-day MA has risen 0.4%.

Keywords: unusual volume progenics pharm

Ticker(s): PGNX